Founded in 2009, Abon Pharmaceuticals is a Chestnut Ridge specialty pharmaceutical company developing complex generic and proprietary medicines, with particular expertise in drug delivery and challenging dosage forms. Its science-led team works from formulation and process design through analytical and pharmacokinetic development, supported by a pilot plant, analytical laboratory, and GMP manufacturing suite opened at its new facility in 2023. Abon has received FDA approvals for generic oral suspensions and an injectable product, including sucralfate oral suspension in 2024.
STI Pharma, LLCFounded in 2008 by industry executive Anup Dam, privately owned STI Pharma develops, licenses, acquires and commercializes generic medicines. The company manages product development and regulatory support in-house, while its commercial products are made at FDA-registered partner facilities and distributed across the United States and its territories. STI is particularly active in specialty and injectable generics, including recent launches such as thiotepa and isoproterenol hydrochloride.NEWTOWN, PA
ScieGen PharmaceuticalsFounded in 2009, ScieGen Pharmaceuticals develops and manufactures finished-dose generic medicines, with its products made in the United States at cGMP facilities in Hauppauge, New York. Its Long Island operation spans more than 250,000 square feet and is designed for annual production of over 10 billion tablet and capsule units, supported by formulation and analytical research in Hyderabad, India. The company has filed more than 75 ANDAs and distributes generic drugs across a broad range of therapeutic categories.HAUPPAUGE, NY
WES Pharma IncFrom its 32,000-square-foot facility in Westminster, WES Pharma Inc develops and manufactures technology-driven specialty generic drugs for U.S. markets, spanning both prescription and over-the-counter products. The privately owned company takes products from in-house research and formulation through FDA approval and manufacturing, with particular focus on technically difficult, niche medicines. Its scientific team works across solid and liquid dosage forms, including products facing solubility, stability, and complex bioequivalence challenges.WESTMINSTER, MD
Pharmaceutics International, Inc. (Pii)Founded in 1994, Pharmaceutics International, Inc. (Pii) is a Hunt Valley drug product contract development and manufacturing organization that takes pharmaceutical products from early development through clinical trials and commercial production. Now part of Jabil, Pii combines more than 30 years of complex-formulation experience with a 360,000-square-foot, four-site campus and more than 300 scientists and support staff. Its GMP facilities are built for demanding work, including potent compounds, complex injectables and oral drug products, with FDA-licensed and DEA-registered operations.HUNT VALLEY, MD